Annotation Detail

Information
Associated Genes
SLCO1B1
Associated Variants
SLCO1B1 p.Val174Ala (p.V174A) ( ENST00000256958.3 )
SLCO1B1 p.Val174Ala (p.V174A) ( ENST00000256958.3 )
Associated Disease
cancer
Source Database
CIViC Evidence
Description
499 children from ALL trials treated with methotrexate were genotyped for 8 SNPs in 5 genes. The SLCO1B1 rs4149056 variant was significantly associated with MTX AUC0-48h and as such associated with increased toxicity.
Variant Origin
Common Germline
Variant Origin
Common Germline
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/1841
Gene URL
https://civic.genome.wustl.edu/links/genes/8450
Variant URL
https://civic.genome.wustl.edu/links/variants/777
Rating
3
Evidence Type
Predictive
Disease
Cancer
Evidence Direction
Supports
Drug
Methotrexate
Evidence Level
B
Clinical Significance
Adverse Response
Pubmed
23652803
Drugs
Drug NameSensitivitySupported
MethotrexateAdverse Responsetrue